Latin America Infectious Disease Molecular Diagnostics Market Size & Outlook
Latin America infectious disease molecular diagnostics market, 2018-2030 (US$M)
Related Markets
Latin America infectious disease molecular diagnostics market highlights
- The Latin America infectious disease molecular diagnostics market generated a revenue of USD 735.9 million in 2024.
- The market is expected to grow at a CAGR of 5.8% from 2025 to 2030.
- In terms of segment, reagents product was the largest revenue generating product in 2024.
- Others Product is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Brazil is expected to register the highest CAGR from 2025 to 2030.
Latin America data book summary
| Market revenue in 2024 | USD 735.9 million |
| Market revenue in 2030 | USD 1,034.5 million |
| Growth rate | 5.8% (CAGR from 2025 to 2030) |
| Largest segment | Reagents product |
| Fastest growing segment | Others Product |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments Product, Reagents Product, Others Product |
| Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
Other key industry trends
- In terms of revenue, Latin America region accounted for 4.6% of the global infectious disease molecular diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Latin America is the fastest growing regional market and is projected to reach USD 1,034.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Infectious Disease Molecular Diagnostics Market Scope
Infectious Disease Molecular Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Latin America infectious disease molecular diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents product was the largest segment with a revenue share of 67.59% in 2024. Horizon Databook has segmented the Latin America infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
Latin America includes Brazil, Mexico, and Argentina. Technological developments are expected to contribute to market growth. In addition, increase in government spending, rising number of skilled healthcare professionals, rise in focus of multinational diagnostic companies on development of advanced & novel infectious diseases molecular diagnostics are likely to drive growth of infectious diseases molecular diagnostics market in Latin America.
Low awareness about the prevention & treatment of infectious diseases in undeveloped areas, high cost of treatment, and the lack of favorable reimbursement policies are some of the key factors restraining market growth.
However, a slow rise in disposable income and growing consumer awareness are a few factors promoting growth. Latin America is expected to grow at a healthy rate owing to government initiatives on regulations and reimbursement of lab tests and trials.
Reasons to subscribe to Latin America infectious disease molecular diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America infectious disease molecular diagnostics market databook
-
Our clientele includes a mix of infectious disease molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America infectious disease molecular diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America infectious disease molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America infectious disease molecular diagnostics market size, by country, 2018-2030 (US$M)
Latin America Infectious Disease Molecular Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
